15 November 2023

Chemist in Industry

Organised by:

SCI’s Fine Chemicals Group and SCI’s Young Chemists’ Panel

Vertex pharmaceuticals, UK

Registration Closed

This event is no longer available for registration.

Synopsis

Following the success of the Young Chemist in Industry event, we are launching a sister award and meeting for a Chemist in Industry. Solving chemistry problems is central to so many industries and it is the people in the laboratories who are making this happen. This is a meeting to celebrate and recognise that community.

This one-day meeting will be of interest to chemists working in different chemical industries (e.g. pharmaceutical, catalysis, agrochemical). Particularly laboratory-based scientists or technical experts (for example, computational chemists) with several years' industry experience. Perhaps you are in a second or third role in industry. It presents a superb opportunity for chemists to showcase the relevance of chemistry to industrial research. It will also provide an opportunity for attendees to develop their CV with presentation and networking skills opportunities. Prizes will be awarded for the best talk and runners-up.

Attendees

SCI's Chemist in Industry one-day meeting will be of interest to chemists working in different chemical industries (pharmaceutical, catalysis, agrochemical). It presents an opportunity to learn about how new chemistry methodology and technology is being developed and used in different industries.

Chair of judging panel: Peter Jones, Vertex Pharmaceuticals

Judging Panel: Simon Peace GlaxoSmithKline, Liz Jones Syngenta

Call for Posters

Opportunities are available for a limited number of posters which align with the theme of the meeting. Interested applicants should send an abstract of maximum one A4 page or 300 words, indicating title and authors to conferences@soci.org by Monday 16 October 2023 with the subject line “Chemist in industry – poster submission”. An abstract template can be downloaded here.

Sponsorship Information

For further information and prices, please email conferences@soci.org.

Programme

Wednesday 15 November 2023

09.30: Registration
09.50: Introduction and welcome
Tilly Bingham
10.00: Biocatalytic reductive amination: from enzyme discovery to manufacturing
Sarah l. Montgomery, Johnson Matthey
10.30: Stereogenic fluorinated carbon in medicinal chemistry: from drug discovery to development
Tim Nicholas Barrett, GSK
11.00: Break
11.30: Discovery of potent & selective Nuak1 inhibitors
Karine G. Poullennec, UCB Biopharma
12.00: Discovery and optimisation of potent and orally available CTP synthetase inhibitors
Andrew Novak, Sygnature
12.30: Solid form control of a drug substance: ensuring robustness during scale-up
Jen Morton, Concept Life Sciences
13.00: Lunch and networking poster session
14.30: Scaffold hopping strategies in the discovery and optimization of thiazolopyridine herbicides
David M. Barber, Bayer
15.00: Development of general, scalable and enantioselective routes to herbicidal DHOD inhibitors
Katharine Ingram, Syngenta
15.30: Networking coffee break and judging discussion
16.00: The human factor: impact of chemists on the identification of a potential therapy for idiopathic pulmonary fibrosis
Simon Peace, GSK
16.45: Award
17.00: Drinks mixer and networking

Travel to the site

Thames Travel provides Milton Park with regular connections between Didcot and further afield.

https://bit.ly/Milton_Park

Parking

There is availability for parking at the site.

Venue and Contact

Vertex Pharmaceuticals

86-88 Jubilee Avenue
Milton Park, Abingdon, Oxfordshire OX14 4RW
United Kingdom
Oxford
UK

Conference Team

Tel: +44 (0)20 7598 1561

Email: conferences@soci.org

Fees

This is a free event.

Become an SCI Member and save on this and future events

See Membership Options

Booking Process/Deadlines

Booking terms and conditions

CPD Info

SCI Members attending this meeting are able to claim CPD points.

Exhibitors

Organising Committee

Tilly Bingham, Cumulus Oncology
Beatriz Dominguez, Johnson Matthey
Stefano Levanto Charles River Laboratories
Joanne Pinder, Vertex Pharmaceuticals